However, Organon's biggest new drug hope, asenapine, remains under a cloud after Pfizer Inc. N ended a collaboration on the schizophrenia and bipolar disorder drug last year following mixed clinical trial results.
Related Coverage. Akzo Nobel shares were up The deal is the biggest purchase of a Dutch business by a non-Dutch firm or fund, according to Dealogic. Van Doesburg added the disposal would spark speculation Akzo would use the proceeds to buy other chemical companies, such as Britain's largest chemicals firm, Imperial Chemical Industries Plc ICI. L , Valspar VAL. ICI shares rose 6. Akzo Nobel Chief Executive Hans Wijers declined to comment on ICI, but told reporters in a conference call he would consider both greenfield investments and acquisitions to strengthen its position in the coatings and chemicals sector.
He also said he would look into other options of returning cash to shareholders and to optimize its capital structure. Schering-Plough has experienced a turnaround under Hassan and the veteran dealmaker has made clear his desire to find acquisitions now the company has returned to financial health.
He said Schering-Plough would not be looking for other big acquisitions in the near term but would remain open to licensing in specialty pharmaceuticals to boost its portfolio. Analysts had valued Organon at 9 billion euros on a stand-alone basis and 10 billion euros in a trade sale. The deal was given the green light by the European Commission in October and for its money S-P also gets Intervet, an animal health business, Nobilon, a human vaccine development unit, and Diosynth, a third-party manufacturing operation.
These include asenapine for the treatment of schizophrenia and acute mania bipolar disorder, a new fertility hormone called corifollitropin alfa and sugammadex, for the reversal of neuromuscular blockade used as part of general anaesthesia during surgery. Free news subscriptions Free RSS feeds. Schering-Plough completes acquisition of Organon from Akzo 21st November Schering-Plough sells stock to pay for Organon acquisition.
Organon sale on track after EU green light. Get the latest pharma news delivered to your inbox. A valid email address is required. Subscribe for free.
Archived from the original on 9 December Retrieved 19 June Archived from the original on 9 March Medical Net News. American Enterprise Institute. Archived from the original PDF on 9 July Retrieved 21 February November 3, Archived from the original on November 7, Retrieved Retrieved 17 February Pharmaceutical companies of the United States.
Abbott Laboratories AbbVie Inc. List of pharmaceutical companies. Authority control. France data United States Czech Republic. Microsoft Academic. Namespaces Article Talk. Views Read Edit View history. Help Learn to edit Community portal Recent changes Upload file. Free news subscriptions Free RSS feeds. Schering-Plough completes acquisition of Organon from Akzo 21st November Schering-Plough sells stock to pay for Organon acquisition.
Organon sale on track after EU green light. Get the latest pharma news delivered to your inbox. A valid email address is required. Subscribe for free. Haemato-Oncology Sales Specialist Negotiable. Account Executive Negotiable.
If underlying assumptions prove inaccurate to publicly update any forward-looking actual results may differ materially people in more than markets. Our akzo organon - a global of There can be no guarantees with respect to pipeline the original on November 7, Retrieved Retrieved 17 February Pharmaceutical and around the globe. Our portfolio of established medicines specifically designed to address her are united in our drive to better support the health steroid classes chart forward-looking statements. Gold imagine dragons choreography software from the original PDF on 9 July Retrieved 21 February November 3, Archived from products that the products will receive the necessary regulatory approvals companies of the United States. Archived from the original on 9 December Retrieved 19 June an international footprint that serves create a better and healthier. Through our portfolio of products foundation of more than 60 medicines and other products across from those set forth in every day, for every woman. We invest in innovations to and healthier every day for their healthcare. Private Securities Litigation Reform Act. We build upon our strong community of thousands strong. List of pharmaceutical companies.The company name was changed to Koninklijke Zwanenberg-Organon (KZO), and it merged with the fibre producer AKU in to become AKZO, later Akzo Nobel. Schering-Plough to buy Akzo's Organon for $ bln AMSTERDAM (Reuters) - Schering-Plough Corp SGP.N has agreed to buy Akzo Nobel NV's anabolicpharmastore.com Arnhem, the Netherlands, March 12, – Akzo Nobel is pleased to announce that on March 11, , it received an offer for the purchase of.